DJ Catalyst Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Catalyst Pharmaceuticals Inc. $(CPRX)$ slid 4.31% to $23.07 Friday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 5.82% to 15,587.79 and Dow Jones Industrial Average falling 5.50% to 38,314.86.
This was the stock's second consecutive day of losses.
Catalyst Pharmaceuticals Inc. closed 11.81% short of its 52-week high of $26.16, which the company achieved on March 24th.
The stock demonstrated a mixed performance when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ fell 4.12% to $153.24, Pfizer Inc. $(PFE)$ fell 5.43% to $22.97, and Abbott Laboratories $(ABT)$ fell 5.46% to $124.44.
Trading volume (2.2 M) eclipsed its 50-day average volume of 1.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled April 4, 2025.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
April 04, 2025 17:19 ET (21:19 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。